Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Nektar Therapeutics (NASDAQ:NKTR)

21.52
BATS BZX Real-Time Price
As of 12:48pm ET
 -0.23 / -1.06%
Today’s Change
11.41
Today|||52-Week Range
24.88
+75.39%
Year-to-Date

Today’s Trading

Previous close21.75
Today’s open21.73
Day’s range21.39 - 21.82
Volume36,496
Average volume (3 months)1,187,480
Market cap$3.4B
Dividend yield--
Data as of 12:48pm ET, 09/20/2017

Growth & Valuation

Earnings growth (last year)-80.33%
Earnings growth (this year)+15.91%
Earnings growth (next 5 years)-7.38%
Revenue growth (last year)-28.32%
P/E ratioNM
Price/Sales10.35
Price/Book37.81

Competitors

 Today’s
change
Today’s
% change
AVXSAveXis Inc+3.03+3.21%
ONCESpark Therapeutics I...+0.88+1.03%
XONIntrexon Corp-0.02-0.11%
JUNOJuno Therapeutics In...+1.38+3.15%
Data as of 12:50pm ET, 09/20/2017

Financials

Next reporting dateNovember 9, 2017
EPS forecast (this quarter)$0.11
Annual revenue (last year)$165.4M
Annual profit (last year)-$153.5M
Net profit margin-92.80%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Howard W. Robin
Chief Operating Officer &
Senior Vice President
John Nicholson
Corporate headquarters
San Francisco, California

Forecasts